CIDRAP newsletters options
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
An intervention to reduce antibiotic treatment for asymptomatic bacteriuria (ASB) at a Toronto hospital was safe and associated with reduced exposure to unnecessary antibiotics, Canadian researchers reported this week in Infection Control and Hospital Epidemiology.
Today The Lancet published the results of two nonrandomized trials (called Sputnik V) of a Russian COVID-19 vaccine candidate, which showed no serious adverse events and demonstrated that the vaccine elicited an antibody response in study participants within 21 days of administration. The phase 1/2 trials were conducted in 76 healthy adults.
Depression has tripled in all groups, but especially in those with money stressors.
"We will never submit ... any vaccine before we feel that it is safe and effective."
Joe Biden says if President Trump had responded early, US schools would be open safely by now.
Also, the Trump administration announces next steps for pulling out of the WHO, and Sanofi and GSK announce a new vaccine trial.
One more Ebola case has been reported in the Democratic Republic of the Congo (DRC) Equateur province outbreak, lifting the overall total to 110, the World Health Organization (WHO) African regional office said in a Twitter update today.
No new deaths have been reported, keeping the outbreak's fatality count at 47.
Residents ventured out about 98% less in most counties in the 42 US states and territories that issued stay-at-home orders to contain SARS-CoV-2, the virus that causes COVID-19.
Iowa has replaced Texas, Florida, and Arizona as the nation's COVID-19 hot spot, with an almost 11% positive testing rate.
The WHO updates its guidance based on data from 3 trials and a meta-analysis.
Nearly 570,000 healthcare workers in the Americas have fallen ill with COVID, and more than 2,500 have died.
Healthcare workers, first responders, and adults with pre-existing conditions that put them at risk for severe symptoms of COVID-19 should be the initial recipients of the first approved vaccine in the United States, according to a framework from the National Academy of Medicine (NAM) published yesterday. Today, NAM will hold a virtual public meeting on the recommendations.
A systematic review and meta-analysis of 62 studies has found that immunity conferred by the measles, mumps, and rubella (MMR) vaccine fades each subsequent year, suggesting that vaccination strategies should be revisited.
Ontario has an 84-week backlog of nonurgent surgeries delayed because of COVID-19.
New guidelines say mass azithromycin should be considered in infants in sub-Saharan African countries with high childhood mortality.
AstraZeneca plans to test its vaccine in 30,000 healthy adults.
In other developments, Japan signaled it will participate in the WHO's COVAX program, as the US declined.
In response to COVID-19, the US government sold $1.5 trillion in obligations such as bonds and spent $1.3 trillion on public health, homeland security, and economic relief by Jun 30, according to an update yesterday from the Government Accountability Office (GAO).
A "proactive hunting surveillance" approach of shooting and testing deer likely to harbor the causative agent of chronic wasting disease (CWD) without leading to undesirable population declines achieved a 99% CWD-free rate within 3 to 5 years, in comparison to 10 years using the typical preemptive sampling strategy, according to a Norwegian modeling study published today in Nature Communications.
